Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive Quetiapine for Refractory Social Anxiety Disorder
NCT01224067Phase 4Completed
- Sponsor
- Cambridge Health Alliance
- Start
- Mar 2006
- Primary completion
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of quetiapine in Social Anxiety Disorder (SAD), sponsored by Cambridge Health Alliance. Started Mar 2006; status: completed.
02
Drugs
quetiapine
03
Conditions
Social Anxiety Disorder (SAD)
Beyond the preview
Go deeper on NCT01224067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01224067.